Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Ashrafpour, Homa ^a   Huang, Ning ^a   Neligan, Peter C ^a,b   Forrest, Christopher R ^a,b   Addison, Patrick D ^a,b   Moses, Michael A ^a,b   Levine, Ronald H ^b   Pang, Cho Y ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Nitric oxide; Prostacyclin; Signaling pathways; Skin flap; VEGF165 receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CALCIUM ION; ENDOTHELIN 1; INOSITOL 1,4,5 TRISPHOSPHATE; NITRIC OXIDE; NORADRENALIN; PHOSPHOLIPASE C; PROTEIN KINASE C; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2 ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FLUOROMETRY; GANGRENE; GENE THERAPY; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; SKIN FLAP; SKIN PERMEABILITY; SWINE; VASODILATATION;

EID: 1342304203     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00901.2003     Document Type: Article

References (47)

1. Acland RD. Experimental skin flap transfer by microvascular anastomosis. In: Skin Flaps, edited by Grabb WC and Myers MB. Boston, MA: Little, Brown, 1976, p. 93-106.
2. Black CE, Huang N, Neligan PC, Levine RH, Lipa JE, Lintlop S, Forrest CR, and Pang CY. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. Am J Physiol Regul Integr Comp Physiol 281: R1097-R1104, 2001.
3. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, and Tsang MLS. Heterodimers of placenta growth factor/vascular endothelial growth factor. J Biol Chem 271: 3154-3162, 1996.
4. Daniel RK and Kerrigan CL. The omnipotential pig buttock skin flap. Plast Reconstr Surg 70: 11-16, 1982.
5. Daniel RK and Kerrigan CL. Principles and physiology of skin flap surgery. In: Plastic Surgery, edited by McCarthy JG. Philadelphia, PA: Saunders, 1990, vol. 1, p. 225-378.
6. Davidge ST, Baker PN, McLaughlin MK, and Roberts JM. Nitric oxide produced by endothelial cells increase production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77: 274-283, 1995.
7. 1) in augmentation of skin flap blood flow and viability in the pig. Prostaglandins 41: 537-558, 1991.
8. Fu BM and Shen S. Structural mechanism of acute VEGF effect on microvessel permeability. Am J Physiol Heart Circ Physiol 284: H2124-H2135, 2003.
9. Gille H, Kowalski J, Li B, Le Couter J, Moffat B, Zioncheck TF, Pelletier N, and Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). J Biol Chem 276: 3222-3230, 2001.
10. Grabb WC. Introduction to the clinical aspects of skin flaps. In: Skin Flaps, edited by Grabb WC and Myers MB. Boston, MA: Little, Brown, 1975, p. 135-143.
11. Grabb WC. Techniques in plastic surgery. In: Plastic Surgery, edited by WC Grabb and Smith JW. Boston: Little, Brown, 1986, p. 3-74.
12. Gurunluoghy Ozer KR, Skugor B, Lubiatowski P, Carnevale K, and Siemionow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann Plast Surg 49: 161-169, 2002.
13. He H, Venema VJ, Gu X, Venema RC, Marrero MB, and Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and Prostacyclin through Flk-1/KDR activation of c-Src. J Biol Chem 274: 25130-25135, 1999.
14. He W, Neligan P, Lipa JE, Forrest CR, and Pang CY. Comparison of secondary ischemic tolerance between pedicled and free island buttock skin flaps in the pig. Plast Reconstr Surg 100: 72-81, 1997.
15. Jeremy JY, Dashwood MR, Mehta D, Izzat MB, Shukla N, and Angelini GD. Nitric oxide, prostacycline and cyclic nucleotide formation in externally stented porcine vein grafts. Atherosclerosis 141: 297-305, 1998.
16. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, Tabayashi K, Shibuya M, and Sato Y. Roles of two VEGF receptors. Flt-1 and KDR in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 19: 2138-2146, 2000.
17. Kerrigan CL and Daniel RK. Critical ischemia time and the failing skin flap. Plast Reconstr Surg 69: 986-989, 1982.
18. Krum JM, Mani N, and Rosenstein JM. Angiogenic and astroglial response to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110: 589-604, 2002.
19. Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, and Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 53: 234-239, 2000.
20. Ku DD, Zaleski JK, Liu S, and Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol Heart Circ Physiol 265: H586-H592, 1993.
21. Li B, Ogusawara AK, Wei W, He GW, Zioncheck TF, Bunting S, de Vos AM, and Jin H. KDR (VEGF receptor 2) is the major meidator for the hypotensive effect of VEGF. Hypertension 39: 1095-1100, 2002.
22. Liu MH, Jin H, Floten S, Ren Z, Yin APC, and He GW. Vascular endothelial growth factor-mediatated endothelium-dependent relaxation in human internal mammary artery, Ann Thorac Surg 73: 819-824, 2002.
23. Lopez JJ, Lahan RJ, Carrozza JP, Rofukuji M, Selke FW, Bunting S, and Simons M. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol Heart Circ Physiol 273: H1317-H1323, 1997.
24. Metais C, Li J, Simons M, and Sellke FW. Effects of coronary artery disease on expression and microvascular response to VEGF. Am J Physiol Heart Circ Physiol 275: H1411-H1418, 1998.
25. Meyer M, Clauss M, Lepple-Weinhues Waltenberrger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ, and Dehio C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO J 18: 363-374, 1999.
26. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, and Ullrich A. High-affinity VEGF binding and development expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846, 1993.
27. Monteiro-Riviere NA, Baynes RE, and Riviere JE. Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. Toxicology 183: 15-28, 2003.
28. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, and Isner JM. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107, 1998.
29. Murphy JF and Fitzgerald DJ. Vascular endothelial cell growth factor (VEGF) induces cyclooxygenase (COX)-dependent proliferation of endothelial cells (EC) via the VEGF-2 receptor. The FASEB Journal 15: 1667-1669, 2001.
30. O'Toole G, MacKenzie D, Lindeman R, Buckley MF, Marucci D, McCarthy N, and Poole M. Vascular endothelial growth factor gene therapy in ischemic rat skin flaps. Br J Plast Surg 55: 55-58, 2002.
31. Padubidri A and Browne E. Effect of vascular endothelial growth factor on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 37: 604-611, 1996.
32. Pang CY, Forrest CR, and Morris SF. Pharmacologic augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon or a wishful thought. Ann Plast Surg 22: 293-306, 1989.
33. Pang CY, Xu H, Huang N, Forrest CR, Perreault TM, and Neligan P. Amplification effect and mechanism of action of endothelin-I in U 46619-induced vasoconstriction in pig skin. Am J Physiol Regul Integr Comp Physiol 280: R713-R7200, 2001.
34. Pang CY, Yang RZ, Neligan P, Xu N, Chiu C, Zhong A, and Forrest CR. Vascular effects and mechanism of action of endothelin-1 in isolated perfused pig skin. J Appl Physiol 79: 2106-2113, 1995.
35. Pang CY, Zhang J, Xu H, Lipa JE, Forrest CR, and Neligan P. Role and mechanism of endothelin-B reccpetors in mediating ET-1-induced vasoconstriction in pig skin. Am J Physiol Regul Integr Comp Physiol 275: R1066-R1074, 1998.
36. Park JE, Chen HH, Winer J, Houck KA, and Ferrara N. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity in vitro and in vivo and high affinity binding to Flt-1/KDR. J Biol Chem 269: 25646-25654, 1994.
37. Pu LLQ, Ahmed S, Thomson JG, Reid MA, Madsen JA, and Restifo RJ. Endothelial cell growth factor enhances musculocutaneous flap survival through the process of neovascularization. Ann Plast Surg 42: 306-312, 1999.
38. Randall MD, Edwards DH, and Griffin TM. Activities of endothelin-I in the vascular network of the rabbit ear: a microangiographic study. Br J Pharmacol 101: 781-788, 1990.
39. Riviere JE. Isolated perfused porcine skin flap system. Pharm Biotechol 8: 387-407, 1996.
40. Riviere JE, Bowman KF, Monteiro-Riviere NA, Dix LP, and Caver MP. The isolated perfused porcine skin flap (IPPSF). A novel model for percutaneous absorption and cutaneous toxicology studies. Fund Appl Toxicol 7: 444-453, 1986.
41. Selke FW, Wang SY, Stamler CV, Lopez JJ, Li J, Li J, and Simons M. Enhances microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol Heart Circ Physiol 271: H713-H720, 1996.
42. Shen BQ, Lee DY, and Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274: 3305-3063, 1999.
43. Thomson JG and Kerrigan CL. Dermofluorometry: thresholds for predicting flap survival. Plast Reconstr Surg 83: 839-864, 1989.
44. Van-der-Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, and Isner JM. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95: 1030-1037, 1997.
45. 2 in endothelial cells via p42/44 mitogen-activated protein kinase. FEBS letters 420: 28-32, 1997.
46. Wu HM, Yuan Y, Zawieja DC, Tinsley J, and Granger HJ. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol Heart Circ Physiol 276: H535-H542, 1999.
47. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, and Bolli R. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279: H2360-H2371, 2000.